Literature DB >> 2005778

Lyme disease: clinical features, classification, and epidemiology in the upper midwest.

W Agger1, K L Case, G L Bryant, S M Callister.   

Abstract

Lyme disease can be classified using the terminology of syphilis. In this series of 95 cases from the upper midwest, early cases, defined as an illness of less than 2 months, were more likely to have lived in or recently visited a highly endemic area. Unlike late cases, early cases presented entirely in the nonwinter months (p less than .001). Early disease was further subdivided into primary and secondary disease. Ninety percent of primary and 43% of secondary cases had erythema migrans, while no late cases had active erythema migrans (p less than .001). Clinical manifestations of nonspecific inflammation, except for arthralgia, were more common in early than late disease (p less than .01). In secondary cases, monoarticular arthritis was slightly more common than polyarticular arthritis, with the reverse occurring in late disease (p less than .05). Indirect fluorescent antibody testing revealed a ratio of IgM to IgG antibodies to be helpful in distinguishing early from late disease. Antibacterial therapy in early, primary cases caused Jarisch-Herxheimer reaction 7% of the time. Despite longer and more frequent parenteral therapy, late Lyme disease frequently required retreatment, owing to poor clinical response (p less than .05).

Entities:  

Mesh:

Year:  1991        PMID: 2005778

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  7 in total

1.  False positive ELISA serologic test for Lyme borreliosis in patients with connective tissue diseases.

Authors:  B Keymeulen; G Somers; A Naessens; L A Verbruggen
Journal:  Clin Rheumatol       Date:  1993-12       Impact factor: 2.980

2.  Reassessment of a midwestern Lyme disease focus for Borrelia burgdorferi and the human granulocytic ehrlichiosis agent.

Authors:  Craig A Jackson; Steven D Lovrich; William A Agger; Steven M Callister
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

3.  Oral antibiotic treatment and long-term outcomes of Lyme facial nerve palsy.

Authors:  T J Kowalski; W L Berth; M A Mathiason; W A Agger
Journal:  Infection       Date:  2011-04-27       Impact factor: 3.553

4.  C-terminal region of outer surface protein C binds borreliacidal antibodies in sera from patients with Lyme disease.

Authors:  Dean A Jobe; Steven D Lovrich; Ronald F Schell; Steven M Callister
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

5.  Ability of the borreliacidal antibody test to confirm lyme disease in clinical practice.

Authors:  Steven M Callister; Dean A Jobe; William A Agger; Ronald F Schell; Todd J Kowalski; Steven D Lovrich; Jennifer A Marks
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

6.  Critical Evaluation of the Linkage Between Tick-Based Risk Measures and the Occurrence of Lyme Disease Cases.

Authors:  Lars Eisen; Rebecca J Eisen
Journal:  J Med Entomol       Date:  2016-09-01       Impact factor: 2.278

7.  Anti-p19 antibody treatment exacerbates lyme arthritis and enhances borreliacidal activity.

Authors:  Sara Heil Peterson; Dean T Nardelli; Thomas F Warner; Steven M Callister; Jose R Torrealba; Ronald F Schell
Journal:  Clin Vaccine Immunol       Date:  2007-03-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.